Search

Your search keyword '"Xie, Xiaoliang Sunney"' showing total 239 results

Search Constraints

Start Over You searched for: Author "Xie, Xiaoliang Sunney" Remove constraint Author: "Xie, Xiaoliang Sunney"
239 results on '"Xie, Xiaoliang Sunney"'

Search Results

1. Repeated Omicron exposures override ancestral SARS-CoV-2 immune imprinting

2. Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution

3. BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection

5. A third dose of inactivated vaccine augments the potency, breadth, and duration of anamnestic responses against SARS-CoV-2

6. Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies

10. Humoral immune response to circulating SARS-CoV-2 variants elicited by inactivated and RBD-subunit vaccines

11. Conversion of monoclonal IgG to dimeric and secretory IgA restores neutralizing ability and prevents Infection of Omicron lineages

12. Conversion of monoclonal IgG to dimeric and secretory IgA restores neutralizing ability and prevents infection of Omicron lineages

13. Neutralisation activity of mucosal IgA against XBB sublineages and BA.2.86

15. Repeated Omicron exposures override ancestral SARS-CoV-2 immune imprinting

21. Heterologous inactivated virus/mRNA vaccination response to BF.7, BQ.1.1, and XBB.1

22. Figure S1-S6 from Inferring the Evolution and Progression of Small-Cell Lung Cancer by Single-Cell Sequencing of Circulating Tumor Cells

23. Table S1 from Inferring the Evolution and Progression of Small-Cell Lung Cancer by Single-Cell Sequencing of Circulating Tumor Cells

24. Table S2-S11 from Inferring the Evolution and Progression of Small-Cell Lung Cancer by Single-Cell Sequencing of Circulating Tumor Cells

25. Opposing, spatially-determined epigenetic forces impose restrictions on stochastic olfactory receptor choice

29. Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution

31. Rational identification of potent and broad sarbecovirus-neutralizing antibody cocktails from SARS convalescents

32. Further humoral immunity evasion of emerging SARS-CoV-2 BA.4 and BA.5 subvariants

33. Characterization of the enhanced infectivity and antibody evasion of Omicron BA.2.75

34. Characterizations of enhanced infectivity and antibody evasion of Omicron BA.2.75

35. BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection

36. Circular RNA vaccines against SARS-CoV-2 and emerging variants

37. Disease profile and plasma neutralizing activity of post-vaccination Omicron BA.1 infection in Tianjin, China: a retrospective study

38. Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron

39. Omicron BA.2 specifically evades broad sarbecovirus neutralizing antibodies

40. Structural and functional characterizations of altered infectivity and immune evasion of SARS-CoV-2 Omicron variant

41. Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies

42. Humoral immunogenicity and reactogenicity of CoronaVac or ZF2001 booster after two doses of inactivated vaccine

43. False Coronavirus Disease 2019 Cases due to Contamination by Inactivated Virus Vaccine

44. A third dose of inactivated vaccine augments the potency, breadth, and duration of anamnestic responses against SARS-CoV-2

48. Circular RNA Vaccines against SARS-CoV-2 and Emerging Variants

49. False Coronavirus Disease 2019 Cases due to Contamination by Inactivated Virus Vaccine.

Catalog

Books, media, physical & digital resources